tiprankstipranks

Gary Charles Robb Insider Profile

4 Followers
Gary Charles Robb, CFO at Corcept Therapeutics, holds 12.59K shares in Corcept Therapeutics (Ticker: CORT).
tipranks
Gary Charles Robb

Gary Charles Robb
Corcept Therapeutics (CORT)
CFO

Ranked #27,050 out of 78,624 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+12.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$289K
100.00%
A breakdown of Gary Charles Robb's holdings

Insider Roles

Corcept Therapeutics
(CORT)
CFO
Roles that Gary Charles Robb holds in companies

Most Profitable Insider Trade

Stock:
Corcept Therapeutics
(CORT)
Rating:Informative Buy
Date:May 08, 2017 - May 08, 2018
Return:+86.90%
The most profitable trade made by Gary Charles Robb

Gary Charles Robb's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Corcept Therapeutics
Nov 17, 2020
CFO
Uninformative Buy
$289.42K
Success Rate for
CORT
2 out of 3 profitable transactions on
CORT
67%
Average Return for
CORT
Average return per transaction on
CORT
+12.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 11, 2017
Uninformative Buy
$0.00
-
$0.00
Feb 11, 2019
Uninformative Buy
$0.00
-
$0.00
Nov 17, 2020
Uninformative Buy
$0.00
-
$0.00
Dec 14, 2018
Informative Sell
$475.00K
-
$1.92
+20.00%
Dec 11, 2019
Informative Sell
$411.90K
-
$1.92
-69.40%
List of latest transactions for each holding click on a transaction to see Gary Charles Robb's performance on stock

Gary Charles Robb insider profile FAQ

What is the percentage of profitable transactions made by Gary Charles Robb?
The percentage of profitable transactions made by Gary Charles Robb is 67%.
    What is the average return per transaction made by Gary Charles Robb?
    The average return per transaction made by Gary Charles Robb is 12.50%.
      What stocks does Gary Charles Robb hold?
      Gary Charles Robb holds: CORT stocks.
        What was Gary Charles Robb’s latest transaction?
        Gary Charles Robb latest transaction was an Uninformative Buy of ―.
          What was Gary Charles Robb's most profitable transaction?
          Gary Charles Robb’s most profitable transaction was an Informative Buy of CORT stock on May 8, 2017. The return on the trade was 86.90%.
            What is Gary Charles Robb's role in Corcept Therapeutics?
            Gary Charles Robb's role in Corcept Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.